Q&A: MPI's Hans Lehrach on Combining Deep Sequencing and Predictive Models to Improve Cancer Therapy | GenomeWeb

HansLehrach2_0.jpgName: Hans Lehrach
Age: 62
Position: Director, Max Planck Institute for Molecular Genetics, Berlin; head of Department of Vertebrate Genomics, since 1994
Experience and Education:
Head of Department of Genome Analysis, Imperial Cancer Research Fund, London, 1987-1994

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Browse our free articles
You can still register for access to our free content.

Through a transcriptome study, researchers home in on the activity of inflammation-linked genes in chronically lonely people.

Determining who is and is not an author and where a researcher should fall on a list of authors can be a tricky task, Nature News writes.

In PNAS this week: variant protective against Alzheimer's disease, effect of whole-genome duplication on methylation in rice, and more.

Genome editing is also bringing up questions when applied to farm animals, the New York Times reports.